Clinical Trial Update: Chlorthalidone and HCTZ Impacts on Platelet Activation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining how chlorthalidone and hydrochlorothiazide affect platelet activation in patients with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Chlorthalidone (chlorthalidone)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Creighton University | Conditions: Hypertension | Phase 4 | Status: UNKNOWN